<DOC>
	<DOCNO>NCT00780104</DOCNO>
	<brief_summary>The purpose study evaluate side effect sirolimus ( rapamycin ) give combination chemotherapy ( Mitoxantrone + Etoposide + Cytarabine ( MEC ) ) high risk myeloid leukemia .</brief_summary>
	<brief_title>Sirolimus Combination With MEC High Risk Myeloid Leukemias</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Must histologic evidence advance myeloid leukemia define one following : primary refractory nonM3 AML ; relapse nonM3 AML ; secondary AML ; intermediate poor prognosis de novo AML patient &gt; = 60 year old &gt; = 18 year age ECOG performance status 0 , 1 Able consume oral medication Initial laboratory value : creatinine &lt; = 2.0 mg/dL ; total direct bilirubin &lt; = 1.5/dL ; SGPT ( ALT ) &lt; = 3xULN ; negative pregnancy test woman childbearing potential Ejection fraction &gt; = 45 % Subjects FAM B3 Must receive chemotherapy ( except Hydroxyurea ) Not receive growth factor , except erythropoietin Subjects `` currently active '' second malignancy nonmelanoma skin cancer Subjects uncontrolled high blood pressure , unstable angina , symptomatic congestive heart failure , MI within last 6 month uncontrolled cardiac arrhythmia Subjects take diltiazem Subjects require HIV protease inhibitor AIDSrelated illnesses No evidence cerebellar dysfunction baseline prior cytarabine therapy Not pregnant breastfeed Uncontrolled infection Subjects take Carbamazepine , Rifabutin , Rifampin , Rifapentine , St. John 's wort , Clarithromycin , Cyclosporine , Diltiazem , Erythromycin , Telithromycin , Verapamil , Tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Advanced myeloid leukemia</keyword>
	<keyword>AML</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Relapsed myeloid leukemia</keyword>
	<keyword>Refractory myeloid leukemia</keyword>
	<keyword>MEC</keyword>
	<keyword>Rapamycin</keyword>
	<keyword>Sirolimus</keyword>
</DOC>